Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Vladimir I. Chupakhin is active.

Publication


Featured researches published by Vladimir I. Chupakhin.


Journal of Molecular Graphics & Modelling | 2009

Molecular modeling of ligand–receptor interactions in GABAC receptor

Dmitry I. Osolodkin; Vladimir I. Chupakhin; V. A. Palyulin; Nikolay S. Zefirov

A new homology model of the GABA binding site of the GABA(C) receptor was built. Natural agonist GABA and antagonist TPMPA were docked into the receptor and molecular dynamics simulation of the complexes was performed to clarify binding poses of the ligands. It was shown that orientation of the ligand is defined by salt bridges between the ligand and the arginine (Arg104) and glutamate residues (Glu194 and Glu196) of the binding site. Different behavior and binding poses for agonist and antagonist was demonstrated by molecular dynamics simulation along with differential movement of the loop C during agonist and antagonist binding. Binding orientations of the ligands revealed that main binding forces in the GABA binding site should be electrostatic ones.


Doklady Biochemistry and Biophysics | 2007

Modeling and analysis of ligand-receptor interactions in the GABAC receptor

Dmitry I. Osolodkin; Vladimir I. Chupakhin; V. A. Palyulin; N. S. Zefirov

25 γ -Aminobutyric acid (GABA) is the major inhibitory transmitter in the human central nervous system. Ligands of GABA receptors may be potential drugs for treating various neurological disorders, such as Parkinson’s and Alzheimer’s diseases, sleep disorders (insomnia and narcolepsy), and epilepsy.


Journal of Cheminformatics | 2010

Ionotropic GABA receptors: modelling and design of selective ligands

V. A. Palyulin; E. V. Radchenko; Dmitry I. Osolodkin; Vladimir I. Chupakhin; Nikolai S. Zefirov

Ionotropic GABAA and GABAC receptors play an important role in the operation of CNS and serve as targets for many neuroactive drugs. Using the homology modelling and molecular dynamics, the 3D models of the receptors were built and some aspects of ligand-target interactions were elucidated [1,2]. To better understand the structural factors controlling the activity and selectivity of the ligands, a series of QSAR models [3] were derived based on the Molecular Field Topology Analysis (MFTA) [4], CoMFA and Topomer CoMFA approaches. They were compared with each other as well as with the molecular modelling results. Finally, a number of potential selective ligand structures were identified by means of the virtual screening [5] from the available chemicals databases and the generated structure libraries.


Tetrahedron-asymmetry | 2013

Asymmetric synthesis and molecular docking study of enantiomerically pure pyrrolidine derivatives with potential antithrombin activity

Seylan Ayan; Oezdemir Dogan; Polina M. Ivantcova; Nikita G. Datsuk; D. A. Shulga; Vladimir I. Chupakhin; Dmitry V. Zabolotnev; Konstantin V. Kudryavtsev


Organic and Biomolecular Chemistry | 2013

Synthesis of PDE IV inhibitors. First asymmetric synthesis of two of GlaxoSmithKline's highly potent Rolipram analogues

Petr A. Zhmurov; Alexey Yu. Sukhorukov; Vladimir I. Chupakhin; Yulia V. Khomutova; S. L. Ioffe; V. A. Tartakovsky


Doklady Biochemistry and Biophysics | 2006

Modeling the open and closed forms of GABAA receptor: Analysis of ligand-receptor interactions for the GABA-binding site

Vladimir I. Chupakhin; V. A. Palyulin; N. S. Zefirov


Tetrahedron | 2014

Synthesis of novel bridged dinitrogen heterocycles and their evaluation as potential fragments for the design of biologically active compounds

Konstantin V. Kudryavtsev; D. A. Shulga; Vladimir I. Chupakhin; Elena I. Sinauridze; Fazly I. Ataullakhanov; S. Z. Vatsadze


Doklady Chemistry | 2008

Computer-aided design of selective ligands of the benzodiazepine-binding site of the GABA(A) receptor

Vladimir I. Chupakhin; S. V. Bobrov; E. V. Radchenko; V. A. Palyulin; N. S. Zefirov


9th AFMC International Medicinal Chemistry Symposium in 2013 (AIMECS13). Proceedings | 2013

Novel fragment-sized heterocyclic entities as a source for Aurora-A kinase inhibitors

Konstantin V. Kudryavtsev; Vladimir I. Chupakhin; D. A. Shulga; Jih-Hwa Guh


9th AFMC International Medicinal Chemistry Symposium in 2013 (AIMECS13). Proceedings | 2013

Bridged dinitrogen heterocycles as novel scaffolds for thrombin inhibitors

S. Z. Vatsadze; D. A. Shulga; Vladimir I. Chupakhin; Konstantin V. Kudryavtsev

Collaboration


Dive into the Vladimir I. Chupakhin's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

D. A. Shulga

Moscow State University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Oezdemir Dogan

Middle East Technical University

View shared research outputs
Top Co-Authors

Avatar

Seylan Ayan

Middle East Technical University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge